Bacampicillin
| Clinical data | |
|---|---|
| AHFS/Drugs.com | Micromedex Detailed Consumer Information | 
| Routes of administration | Oral | 
| Drug class | aminopenicillin | 
| ATC code | |
| Pharmacokinetic data | |
| Metabolism | Rapidly hydrolyzed to ampicillin | 
| Identifiers | |
| 
 | |
| CAS Number | 
 | 
| PubChem CID | |
| DrugBank | |
| ChemSpider | |
| UNII | 
 | 
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C21H27N3O7S | 
| Molar mass | 465.52 g·mol−1 | 
| 
 | |
| (what is this?) (verify) | |
Bacampicillin (INN) is a penicillin antibiotic. It is a prodrug of ampicillin with improved oral bioavailability.
It was sold under the brand names Spectrobid (Pfizer) and Penglobe (AstraZeneca).In 2015, Pfizer discontinued Spectrobid, and no generic manufacturer has taken over production. Bacampicillin is thus unavailable in the United States, and is no longer FDA approved.